Immunogenic polypeptide composed of tumor antigen-derived...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2634480

The present invention pertains to the field of anti-cancer vaccines. More particularly, the invention concerns an optimized polypeptide, which comprises three cryptic tumor peptides with enhanced immunogenicity and comprises the amino acids sequence YLQVNSLQTVYLEYRQVPVYLEEITGYL, for use in an anti-cancer vaccine. Nucleic acids encoding such a polypeptide, as well as complexes and dendritic cells engineered with this polypeptide or a nucleic acid encoding it, are also part of the invention.

La présente invention concerne le domaine des vaccins anticancéreux. Plus particulièrement, l'invention concerne un polypeptide optimisé, constitué de trois peptides tumoraux cryptiques ayant une immunogénicité renforcée et comprenant la séquence d'acides aminés YLQVNSLQTVYLEYRQVPVYLEEITGYL, qui est destiné à être utilisé dans un vaccin anticancéreux. L'invention concerne en outre des acides nucléiques codant pour ce polypeptide, ainsi que des complexes et des cellules dendritiques manipulées avec le polypeptide ou un acide nucléique codant pour lui.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunogenic polypeptide composed of tumor antigen-derived... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenic polypeptide composed of tumor antigen-derived..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic polypeptide composed of tumor antigen-derived... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1920792

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.